002030.SZ · 达安基因
China A-shares · RS rating 88 · As of 2026-10-14
| Price | 5.71 CNY |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 87 / 84 / 59 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 22 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +19.4% |
| Distance from 52-week high | +25.9% |
| Market cap (USD) | $1.3B |